Nina Shah

13PUBLICATIONS
99CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical mycologyHaematologyMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jan 21, 2026
Anti-B-cell Maturation Antigen Chimeric Antigen Receptor T-cell Therapy bb21217 for Relapsed and Refractory Multiple Myeloma: Results from the Phase I CRB-402 Study.

Melissa Alsina, Nina Shah, Sundar Jagannath

|Jul 18, 2023
Randomized Phase II Trial of Dendritic Cell/Myeloma Fusion Vaccine with Lenalidomide Maintenance after Upfront Autologous Hematopoietic Cell Transplantation for Multiple Myeloma: BMT CTN 1401.

David J Chung, Nina Shah, Juan Wu

|Apr 06, 2023
Impact of bortezomib-based versus lenalidomide maintenance therapy on outcomes of patients with high-risk multiple myeloma.

Naresh Bumma, Binod Dhakal, Raphael Fraser

|Jan 18, 2022
Digital Life Coaching During Stem Cell Transplantation: Development and Usability Study.

Rahul Banerjee, Chiung-Yu Huang, Lisa Dunn

|Aug 10, 2021
Outcomes of upfront autologous hematopoietic cell transplantation in patients with multiple myeloma who are 75 years old or older.

Pashna N Munshi, David H Vesole, Andrew St Martin

|Jun 22, 2021
Phase I study protocol: NKTR-255 as monotherapy or combined with daratumumab or rituximab in hematologic malignancies.

Nina Shah, Miguel-Angel Perales, Cameron J Turtle

Pageof 3

Frequent Collaborators

4 joint publications

Anita D'Souza

4 joint publications

Shaji Kumar

3 joint publications

Binod Dhakal

3 joint publications

Sundar Jagannath